Literature DB >> 12580645

Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA).

Elliot G Brown1.   

Abstract

The Medical Dictionary for Regulatory Activities (MedDRA) is a unified standard terminology for recording and reporting adverse drug event data. Its introduction is widely seen as a significant improvement on the previous situation, where a multitude of terminologies of widely varying scope and quality were in use. However, there are some complexities that may cause difficulties, and these will form the focus for this paper. Two methods of searching MedDRA-coded databases are described: searching based on term selection from all of MedDRA and searching based on terms in the safety database. There are several potential traps for the unwary in safety searches. There may be multiple locations of relevant terms within a system organ class (SOC) and lack of recognition of appropriate group terms; the user may think that group terms are more inclusive than is the case. MedDRA may distribute terms relevant to one medical condition across several primary SOCs. If the database supports the MedDRA model, it is possible to perform multiaxial searching: while this may help find terms that might have been missed, it is still necessary to consider the entire contents of the SOCs to find all relevant terms and there are many instances of incomplete secondary linkages. It is important to adjust for multiaxiality if data are presented using primary and secondary locations. Other sources for errors in searching are non-intuitive placement and the selection of terms as preferred terms (PTs) that may not be widely recognised. Some MedDRA rules could also result in errors in data retrieval if the individual is unaware of these: in particular, the lack of multiaxial linkages for the Investigations SOC, Social circumstances SOC and Surgical and medical procedures SOC and the requirement that a PT may only be present under one High Level Term (HLT) and one High Level Group Term (HLGT) within any single SOC. Special Search Categories (collections of PTs assembled from various SOCs by searching all of MedDRA) are limited by the small number available and by lack of clarity about criteria applied in their construction. Difficulties in database searching may be addressed by suitable user training and experience, and by central reporting of detected deficiencies in MedDRA. Other remedies may include regulatory guidance on implementation and use of MedDRA. Further systematic review of MedDRA is needed and generation of standardised searches that may be used 'off the shelf' will help, particularly where the same search is performed repeatedly on multiple data sets. Until these enhancements are widely available, MedDRA users should take great care when searching a safety database to ensure that cases are not inadvertently missed.

Mesh:

Year:  2003        PMID: 12580645     DOI: 10.2165/00002018-200326030-00002

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  2 in total

1.  Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART.

Authors:  Elliot G Brown
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Tabulation and analysis of pharmacovigilance data using the medical dictionary for regulatory activities.

Authors:  E Brown Bmedsci Mb Chb Mrcgp Ffpm; S Douglas Bsc
Journal:  Pharmacoepidemiol Drug Saf       Date:  2000-11       Impact factor: 2.890

  2 in total
  21 in total

Review 1.  Using MedDRA: implications for risk management.

Authors:  Elliot G Brown
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions.

Authors:  Cédric Bousquet; Georges Lagier; Agnès Lillo-Le Louët; Christine Le Beller; Alain Venot; Marie-Christine Jaulent
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  What is drug safety?: celebrating 20 years of the Drug Safety journal.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  The Use of the Medical Dictionary for Regulatory Activities in the Identification of Mitochondrial Dysfunction in HIV-Infected Children.

Authors:  Miriam Chernoff; Heather Ford-Chatterton; Marilyn J Crain
Journal:  Case Studies Bus Ind Gov Stat       Date:  2012-10

Review 5.  Ontology-supported research on vaccine efficacy, safety and integrative biological networks.

Authors:  Yongqun He
Journal:  Expert Rev Vaccines       Date:  2014-06-07       Impact factor: 5.217

6.  Bevacizumab versus ranibizumab for neovascular age-related macular degeneration: a Meta-analysis.

Authors:  Wen-Jie Wang; Jian Chen; Xiao-Ling Zhang; Min Yao; Xiao-Yong Liu; Qing Zhou; Yi-Xin Qu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

7.  Towards an ontological theory of substance intolerance and hypersensitivity.

Authors:  William R Hogan
Journal:  J Biomed Inform       Date:  2010-02-10       Impact factor: 6.317

8.  Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system.

Authors:  R Harpaz; W DuMouchel; P LePendu; A Bauer-Mehren; P Ryan; N H Shah
Journal:  Clin Pharmacol Ther       Date:  2013-02-11       Impact factor: 6.875

9.  [Establishment of a rapid identification of adverse drug reaction program in R language implementation based on monitoring data].

Authors:  Dongsheng Hong; Jian Ni; Wenya Shan; Lu Li; Xi Hu; Hongyu Yang; Qingwei Zhao; Xingguo Zhang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

Review 10.  Challenges in coding adverse events in clinical trials: a systematic review.

Authors:  Jeppe Bennekou Schroll; Emma Maund; Peter C Gøtzsche
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.